NEIBARIX Trademark

Trademark Overview


On Friday, February 9, 2024, a trademark application was filed for NEIBARIX with the United States Patent and Trademark Office. The USPTO has given the NEIBARIX trademark a serial number of 98399962. The federal status of this trademark filing is SUSPENSION LETTER - MAILED as of Wednesday, September 4, 2024. This trademark is owned by GlaxoSmithKline Biologicals SA. The NEIBARIX trademark is filed in the Pharmaceutical Products category with the following description:

Vaccines for human use
neibarix

General Information


Serial Number98399962
Word MarkNEIBARIX
Filing DateFriday, February 9, 2024
Status653 - SUSPENSION LETTER - MAILED
Status DateWednesday, September 4, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesVaccines for human use

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, February 9, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameGlaxoSmithKline Biologicals SA
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressRixensart B-1330
BE

Trademark Events


Event DateEvent Description
Friday, February 9, 2024NEW APPLICATION ENTERED
Sunday, June 9, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, August 24, 2024ASSIGNED TO EXAMINER
Wednesday, September 4, 2024SUSPENSION LETTER WRITTEN
Wednesday, September 4, 2024EXAMINERS AMENDMENT E-MAILED
Wednesday, September 4, 2024NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, September 4, 2024LETTER OF SUSPENSION E-MAILED
Wednesday, September 4, 2024NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Wednesday, September 4, 2024EXAMINERS AMENDMENT -WRITTEN
Wednesday, September 4, 2024EXAMINER'S AMENDMENT ENTERED

Related Keywords


neibarix human vaccines